Cefepime/zidebactam
Combination antibiotics
From Wikipedia, the free encyclopedia
Cefepime/zidebactam, sold under the brand name Zaynich, is a fixed-dose combination used for the treatment of complicated urinary tract infections.[1] It contains cefepime, a cephalosporin antibacterial; and zidebactam, a beta-lactamase inhibitor and non-beta-lactam antibacterial.[1]
Trade namesZaynich
| Combination of | |
|---|---|
| Cefepime | Cephalosporin antibacterial |
| Zidebactam | Beta-lactamase inhibitor and non-beta-lactam antibacterial |
| Clinical data | |
| Trade names | Zaynich |
| AHFS/Drugs.com | zaynich |
| License data | |
| Routes of administration | Intravenous |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| KEGG | |
It was approved for medical use in the United States in May 2026.[2]
Medical uses
Cefepime/zidebactam is indicated for the treatment of adults with complicated urinary tract infections including pyelonephritis caused by designated susceptible microorganisms.[1]
